Article Information
PubMed
History
- Published online September 6, 2023.
Copyright & Usage
© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Emma A van Reekum, MD*,
- Nicolette Stogios, HBSc*,
- Leah Burton, RN, BSN,
- Harold Spivak, MD,
- Margaret Hahn, MD, PhD,
- Sri Mahavir Agarwal, MBBS, PhD
- From the Department of Psychiatry & Behavioural Neurosciences, McMaster University, Hamilton, Ont. (van Reekum); the Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ont. (van Reekum); the Schizophrenia Division, Centre for Addiction and Mental Health, Toroto, Ont. (Stogios, Burton, Hahn, Agarwal); the Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ont. (Stogios, Hahn, Agarwal); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Spivak, Hahn, Agarwal); the Banting and Best Diabetes Centre, University of Toronto, Toronto, Ont. (Hahn, Agarwal)